We just want to have the products that we need to feed you, he said
Why Sun Pharmas semaglutide approval matters in Indias weight loss drug market Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the patent expiry in March 2026 to tap into demand Earlier today, Sun Pharmaceutical Industries said it had received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection, a glucagonlike peptide1 (GLP1) receptor agonist indicated for chronic weight management in adults
Tirzepatides influence on heart rate may be linked to its action on GLP-1 receptors, which are present in the heart and blood vessels
297 p53 is significantly acetylated at the Lys (118) residue in a rat model of ischemia/reperfusion injury, which regulates p53 binding and accumulation at the Bax promoter
He would sell programs but never any private coaching (which is where the money is in personal training)
Science 314 , 11351139 (2006)
